logo
Share SHARE
FONT-SIZE Plus   Neg

Enzon Mulls Sale Of Assets, Co. - Update

Enzon Pharmaceuticals Inc. (ENZN: Quote) said Monday it is considering a possible sale of some or all of its assets and has retained Lazard as financial advisor in this regard.

Additionally, the company in a statement said, "Based on clinical data on the androgen receptor program, Enzon plans to suspend clinical development with a goal to conserve capital and maximize value returned to shareholders."

Shares of the company gained over five percent in morning trade on the Nasdaq.

Enzon's decision to sell its assets comes after an activist investor expressed interest to hold discussions with the company that develops drugs to treat cancer. Icahn holds a 13.3 percent stake in Enzon.

In a statement, Enzon Chairman Alex Denner said the strategic review will be in the best interest of shareholders. He also said Enzon's drug candidates offer the potential for a variety of transactions that would supplement the royalty revenues the company earns.

Shares of Enzon are trading at $4.82, up 5.47%.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Warner Bros. Interactive Entertainment said its upcoming mobile game releases in 2015 would include Batman, DC Comics, LEGO, "Game of Thrones," and "Mortal Combat X". A study claims the ghastly civil war in Syria is the result of a severe drought brought about by global warming - in what is yet the strongest link between climate change and armed conflict. U.S. electronics giant Apple Inc. (AAPL) regained the top spot in the world smartphone market from South Korea's Samsung Electronics Co Ltd. after a gap of three years, according to a report released Tuesday by market research firm Gartner, Inc. (IT). Apple sold 74.832 million smartphones in the...
comments powered by Disqus
Follow RTT